Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells  by Pai, Rama et al.
Kidney International, VoL 48 (1995), pp. 1254—1262
Low-density lipoprotein stimulates the expression of macrophage
colony-stimulating factor in glomerular mesangial cells
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Low-density lipoprotein stimulates the expression of macrophage col-
ony-stimulating factor in glomerular mesangial cells. Disordered lipopro-
tein metabolism and the enhanced influx and accumulation of circulating
mononuclear leukocytes into vascular tissue are common pathobiological
phenomena associated with both atherosclerosis and glomerulosclerosis.
Since atherogenic lipoproteins (such as low density lipoprotein, LDL)
have been implicated in monocyte migration and proliferation into the
glomerular mesangium, we examined the effect of LDL on mesangial cell
expression of macrophage colony-stimulating factor (M-CSF), a cytoregu-
latory peptide associated with monocyte chemoattraction, differentiation
and proliferation. Mesangial cell M-CSF gene expression, protein synthe-
sis and secretion, and its biological activity to induce progenitor colony
formation and monocyte proliferation were studied in murine mesangial
cells. Incubation of either primary cultures or SV-40 transformed murine
mesangial cells with LDL (0 to 200 gIml) induced M-CSF steady-state
mRNA expression, in a dose-dependent manner (52 to 183% of control)
when Northern blots were analyzed quantitatively by densitometric scan-
ning. Similarly, Western blot analysis showed that LDL-activated SV-40
transformed mesangial cells increased M-CSF protein synthesis and
secretion in a dose-dependent manner. The conditioned media obtained
by incubating mesangial cells with LDL induced bone marrow progenitor
colony formation that could be inhibited by specific neutralizing antibod-
ies against murine M-CSF. Finally, the biological activity of M-CSF
secreted by LDL-activated mesangial cells was further confirmed by its
enhanced ability to induce monocyte proliferation. These data indicate
that LDL, by activating mesangial cells to induce M-CSF and possibly
other monocyte chemoattractants, may regulate the migration and prolif-
eration of cells of mononuclear leukocytic origin into the mcsangium
supporting a pathobiological role for LDL in glomerular injury.
Disturbances in lipoprotein metabolism have been proposed to
play a central pathobiological role in the development of systemic
vascular and glomerular injury both in experimental animals and
humans. In vitro and in vivo studies have strongly suggested that
many biochemical and histological abnormalities seen in glomer-
uloscierosis are analogous to those observed in atherosclerosis
[1—3]. One of these abnormalities, the enhanced migration and
accumulation of circulating monocytes in the mesangium, is a
predominant pathological feature seen early in the development
of glomerulosclerosis [4]. The accumulation of circulating mono-
cytes within the mesangium and monocyte transformation into
tissue macrophages has been described in patients with focal and
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segmental glomerulosclerosis [5] and membranoproliferative gb-
merulonephritis [6, 7]. Mononuclear cell infiltration has also been
shown in various experimental models including antiglomerular
basement membrane disease [8], immune complex nephritis [9],
puromycin aminonucleoside nephrosis [10, iii, renal ablation
[12], and glomerular injury associated with hyperlipidemia or
cholesterol feeding [13—15]. Although the cellular and molecular
mechanisms underlying monocyte infiltration into the glomerulus
are not completely understood, monocyte recruitment into the
mesangium may involve complex receptor-mediated interactions
between resident glomerular cells and circulating monocytes.
These interactions are proposed to be mediated, in part, by the
enhanced expression of glomerular endothelial cell-derived adhe-
sion molecules and by the elaborated expression of monocyte
chemoattractant cytokines by resident glomerular cells [16—18].
Macrophage-colony stimulating factor (M-CSF, also known as
colony stimulating factor-i), granulocyte-macrophage colony
stimulating factor (GM-CSF), and monocyte chemotactic pro-
tein-I (MCP-1) are major cytoregulatory peptides that induce
monocyte chemoattraction and the differentiation and prolifera-
tion of mononuclear phagocytes {i9, 20]. M-CSF is a ho-
modimeric glycoprotein synthesized by a variety of cell types
including glomerular mesangial cells [21, 22]. This cytokine pro-
motes the growth and differentiation of bone marrow progenitor
cells into mononuclear phagocytes [19, 211 and stimulates the
proliferation and immune activation of these cells [19, 231. M-CSF
exists in membrane-bound and secretory forms derived through
alternative splicing of a single gene [24, 25]. The observation of a
positive correlation between the severity of renal injury and the
glomerular expression of M-CSF has provided evidence for a
central role of this cytokine in enhanced monocyte migration,
differentiation and proliferation within the glomerulus associated
with autoimmune-mediated renal injury [26, 27]. Since the in-
creased accumulation of glomerular monocyte/macrophages is a
common pathological phenomenon seen in renal disease, factors
that regulate the recruitment and proliferation of circulating
mononuclear phagocytes in the mesangium may play an early and,
perhaps, critical role in the cascade of events culminating in the
development of glomerular injury. In experimental models of
atherosclerosis, atherogenic lipoproteins have been proposed to
accelerate the pathogenesis of vascular injury by facilitating the
adhesion and migration of monocytes into the subendothelial
space [28, 29]. Since gbomeruboscierosis and atherosclerosis ap-
pear to share common pathobiological mechanisms, it is inviting
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to speculate that atherogenic lipoproteins initiate glomerular
injury by enhancing mesangial expression of cytokines that medi-
ate monocyte chemoattraction and proliferation.
Thus, studies were performed to examine the effect of low-
density lipoprotein (LDL) on glomerular mesangial expression of
M-CSF, an early cellular and molecular events associated with the
pathogenesis of monocyte/macrophage-mediated glomerular in-
jury. In addition, the biological response of M-CSF produced by
LDL-activated mesangial cells was assessed by determining the
effect of mesangial cell conditioned media on bone marrow
progenitor colony formation and macrophage proliferation. The
results indicated that the activation of mesangial cells by LDL
enhanced the gene expression and protein synthesis of M-CSF.
Additionally, LDL-activated mesangial cell conditioned media
stimulated bone marrow progenitor colonies and induced macro-
phage proliferation.
Methods
Materials
Dulbecco's minimal essential media (DMEM), RPMI 1640,
other tissue culture reagents, nitrocellulose membranes, and
peroxidase-conjugated rat anti-IgG were obtained from Sigma
Chemical Company (St. Louis, MO, USA). Fetal bovine serum
(FBS) was obtained from Hyclone Laboratories Inc. (Logan, UT,
USA). Neutralizing murine anti-M-CSF was purchased from
Oncogene Sciences (Manhasset, NY, USA). Deoxycytidine-5'-{cs-
32P]triphosphate (sp. act. = 3000 Ci/mmol) and [methyl-3H]thy-
midine (sp. act. = 2 Ci/mmol) was obtained from Amersham
Corporation (Arlington Heights, IL, USA). A eDNA probe for
human glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was purchased from Clontech (Palo Alto, CA, USA). MSI nylon
transfer membranes were obtained from Fisher Scientific (Tustin,
CA, USA). All other chemicals used were of analytical grade.
LDL isolation
Blood samples were collected from healthy human volunteers,
serum was isolated by centrifugation, and samples were pooled for
LDL isolation. A preservative mixture [30] containing antioxi-
dants, antibiotics, and a protease inhibitor was added to the serum
and LDL isolated by sequential density ultracentrifugation at a
density of 1.063 g/ml [31]. The purity of the LDL was monitored
by agarose gel electrophoresis and its protein content measured
by Lowry's method [32] using bovine serum albumin as a standard.
Freshly isolated LDL samples were used within 30 days. During
this period, LDL was stored at 4°C in the presence of a preser-
vative mixture containing antioxidants, antibiotics, and protease
inhibitors to prevent LDL-oxidative modification.
Cell culture
Primary cultures of murine mesangial cells were isolated from
glomeruli of 6 to 10 weeks old Balb/cJ mice as described by others
[21]. In brief, glomeruli were isolated from finely minced renal
cortical tissue by passing through successively a series of sieves of
decreasing pore size (150, 106, 63 tm). The glomerular prepara-
tion retained on the 63 tm sieve was washed and cultured in
DMEM containing 20% FBS in a 37°C humidified incubator.
Mesangial cell outgrowth was seen by day 7 with a predominance
of mesangial cells after two weeks that demonstrated typical
differentiation characteristics as previously described [21]. Con-
fluent mesangial cells were subcultured by trypsinization and used
for experiments after five passages. Primary cultures of murine
mesangial cells were used to determine M-CSF gene expression in
response to LDL activation. A murine mesangial cell line (MES-
13, cloned from mice transgenic for the early region of SV-40
virus, passage 25) was obtained from the American Type Culture
Collection (ATCC; Rockville, MD, USA). The mesangial cells
were grown in DMEM containing 5% FBS, 1% glutamine-
streptomycin-penicillin mixture, 44 mrvi NaHCO3, and 14 mM
HEPES in an atmosphere of 5% CO2 and 95% air at 37°C in a
humidified incubator. Subcultures were made from confluent
stock cultures by trypsinization in PBS containing 0.5 mrvi EDTA
and 0.025% trypsin. Mesangial cells (70 to 80% confluent) were
incubated in DMEM in the absence or presence of LDL (10 to
200 jgIml) for 48 hours. After incubation, media was collected
and sterilized through 0.22 jm filters, and either used immedi-
ately or stored at —20°C for bone marrow progenitor culture
assays. After removing the media, mesangial cells were collected
and washed three times in phosphate buffered saline (PBS) and
used for RNA isolation. A murine monocyte/macrophage cell line
(J774.A1), obtained from ATCC and cultured in RPMI 1640
supplemented with L-glutamine, penicillin/streptomycin, and 10%
FBS, was used in the proliferation studies.
Bone marrow progenitor culture assay
Forty thousand freshly prepared Balb/cJ (Jackson Labs, Bar
Harbor, ME, USA) bone marrow cells were cultured in DMEM
containing 16% FBS (mycoplasma and viral-free) and 0.8%
methylcellulose [33]. The bone marrow progenitor culture assay
was initiated by the addition of various aliquots of control or
LDL-activated mesangial cell conditioned media to culture flasks
containing murine bone marrow cells and the flasks were then
incubated for seven days in a humidified atmosphere of 5% CO2
and 95% air at 37°C. At the end of the seven days incubation
period, the semisolid methylcellulose medium was visually exam-
ined for colony formation using an inverted microscope. Colonies
containing 50 or more cells were counted as positive.
Immunological characterization of M-CSF
Characterization of factors associated with colony stimulating
activity of LDL-activated-mesangial cell conditioned media was
performed by examining colony formation in the presence of a
specific neutralizing antibody directed against murine M-CSF.
Bone marrow progenitor culture assays were performed as noted
above using control or LDL-activated-mesangial cell conditioned
media (8%) and saturating concentrations of murine anti-M-CSF.
The inhibition of colony growth was determined by comparing the
results obtained in the presence of the neutralizing antibody with
that obtained in its absence.
Monocyte/macrophage proliferation assay
The ability of LDL-activated mesangial cell media to induce
monocyte/macrophage proliferation was performed by using an
assay that examines the incorporation of 3H-thymidine into
cellular DNA. A murine monocyte/macrophage cell line (J774.1)
was grown for 24 hours in 96-well culture plates (1 X i04
cells/well) in 200 il of RPMI 1640 media supplemented with
L-glutamine, penicillin/streptomycin, and 5% FBS. After incuba-
tion, fresh media containing 60 jd of control or LDL-activated
mesangial cell conditioned media was added to the monocyte
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cultures and incubated for 48 hours at 37°C in a humidified 5%
CO2 atmosphere. Eight hours before harvesting the cells, the
individual wells were pulsed with 0.5 Ci of [methyl-3Hlthymi-
dine. After pulsing, the cells were washed three-times with PBS
(4°C), collected on glass wool fiber filters using a multiple sample
cell harvester, and radioactivity measured. Since LDL may di-
rectly influence monocyte/macrophage proliferation, additional
proliferation studies were performed in the presence of equivalent
concentrations of exogenous LDL. Similar proliferation studies
were performed utilizing saturating concentrations of murine
anti-M-CSF to determine whether the observed changes in mono-
cyte/macrophage proliferation were the result of M-CSF secreted
by mesangial cells into the media in response to LDL activation.
Northern blot analysis
After removing the media, mesangial cells were collected and
washed three times with PBS. Total RNA was isolated from the
cells using the protocol of Chomczynski and Sacchi [34]. In brief,
cells were homogenized with 4 M guanidium thiocyanate, total
protein and DNA extracted with acid phenol, and RNA precipi-
tated with isopropanol. After washing with ethanol, samples were
dried under vacuum centrifugation and the amount of RNA
quantitated by measuring the absorbance at 260 nm using a
spectrophotometer. Twenty micrograms of total RNA was loaded
into individual wells of a 1.2% agarose gel containing formalde-
hyde and electrophoresis performed [35]. The RNA from the gel
was transferred onto MSI nylon membranes using a trans-blotting
cell (Bio-Rad, Richmond, CA, USA). The nylon membrane was
UV-linked using a Stratalinker (Stratagene, La Jolla, CA, USA).
The eDNA probes for M-CSF and GAPDH were used for
hybridization after [32P]dCTP-labeling by random oligonucleotide
priming. The membrane was hybridized using a 32P-labeled
murine M-CSF cDNA probe (obtained from Dr. E.R. Stanley,
Albert Einstein Medical Center, Bronx, NY, USA). The mem-
branes were washed three times for 30 minutes: first in 2 >< SSC
with 0.1% SDS at 25°C; second in 0.5 X SSC with 0.1% SDS at
25°C; and third in 0.5 x SSC with 0.1% SDS at 55°C. Autora-
diography was performed by exposing the blots to Kodak X-ray
film with intensifying screens at —70°C. Blots were then rehybrid-
ized with a 32P-labeled human GAPDH eDNA probe as an
internal control to assess RNA quantity and integrity. Quantita-
tion of mRNA signals was performed by densitometric scanning
of autoradiographs and normalized with GAPDH mRNA signals.
Western blot analyses
Immunoblot analyses were performed to determine the synthe-
sis and secretion of M-CSF into the mesangial cell conditioned
media [36]. After mesangial cell incubation with or without LDL,
media was collected and lyophilized. Aliquots of concentrated
media (25 to 30 fold) were mixed with sample buffer containing
SDS and f3-mercaptoethanol and heated at 65°C for 15 minutes.
Samples were applied to 12.5% polyacrylamide gel and electro-
phoresed. A prestained SDS-PAGE standard (broad range, Bio-
Rad) was also electrophoresed as a molecular weight marker.
After electrophoresis, proteins were transferred onto a nitrocel-
lulose membrane using a transblot chamber with Tris buffer.
Western blots were incubated with rat anti-murine M-CSF for two
hours at 25°C, membranes washed with PBS-Tween-20 for one
hour, and incubated with peroxidase-conjugated rat anti-IgG at
25°C for 90 minutes. After washing, the membranes were incu-
bated with a color reagent (50 mg 3,3'-diaminobenzidine, 0.1 ml
H202 in 100 ml PBS) for 15 minutes. Positive immunoreactive
bands were quantitated densitometrically and compared to con-
trols.
Statistical analysis
Results are presented as mean values standard error (SE) for
three to four separate experiments. Student's t-test was used to
compare the means and a P value of less than 0.05 was considered
significant.
Results
We have used both primary cultures and transformed murine
mesangial cells as an in vitro model to study the role of LDL on
glomerular mesangial cell M-CSF gene expression. Further exper-
iments examining the role of LDL on M-CSF protein synthesis
and biological activity were performed in SV-40 transformed
murine mesangial cells. These transformed cells were developed
by cloning mesangial cells from transgenic mice for the early
region of SV-40 virus and have been shown to exhibit similar
morphological and functional characteristics to those of primary
cultures of murine mesangial cells [37]. Besides maintaining
normal differentiation characteristics, transformed mesangial cells
exhibit contractile properties in response to vasoactive substances
and produce various cytokines analogous to primary cultures of
mesangial cells [38—41].
Using a murine bone marrow progenitor colony assay, studies
were performed to examine the ability of LDL-activated mesan-
gial cell conditioned media to alter hematopoietic colony forma-
tion. Conditioned media, obtained by incubating mesangial cells
with LDL (10 to 200 JLg/ml), increased bone marrow progenitor
colony formation in a dose-dependent manner with LDL concen-
trations as low as 25 ig/ml and with a maximal effect at 100 j.tg/ml
(Fig. 1). No further increase in progenitor colony formation was
noted with higher concentrations of LDL. The number of progen-
itor colonies formed in response to LDL-activated mesangial cell
conditioned media increased with higher concentrations of con-
ditioned media (4% vs. 8%; Fig. 1). Additional studies were
performed to determine whether exogenous LDL could indepen-
dently influence the growth of hematopoietic progenitor cells in
the absence of mesangial cell conditioned media. Incubation of
exogenous LDL (in concentrations equivalent to those used in the
studies using LDL-activated conditioned media, 10 to 200 g/ml)
with bone marrow cells for seven days failed to stimulate the
formation of hematopoietic colonies when compared to assays in
the absence of exogenous LDL (data not shown). Thus, these data
did not support an effect of LDL on bone marrow progenitor cell
growth independent of its ability to enhance the mesangial cell
expression of colony stimulating factors.
Additional studies were performed using a neutralizing M-CSF
antibody to determine whether the biological activity of LDL-
activated mesangial cell conditioned media to induce the growth
of murine bone marrow progenitor cells was a result of increased
secretion of M-CSF by mesangial cells. The addition of anti-M-
CSF to bone marrow cultures in the presence of LDL-activated
mesangial cell conditioned media (8%) inhibited 60 to 70% of the
colony stimulating activity induced by LDL-activation of mesang-
ial cells (Fig. 2). These data suggested that the colony stimulating
activity of LDL-activated mesangial supernatants was the result of
increased secretion of biologically active M-CSF into the media.
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Fig. 1. Effect of conditioned media obtained by
incubating mesangial cells with various
concentrations of LDL on the growth of murine
bone marrow progenitor cells. Forty thousand
murine bone marrow cells were grown in 1 ml
DMEM containing 0.8% methylcellulose and
either 4% (A) or 8% (B) LDL-activated
mesangial cell conditioned media. After seven
days of incubation, colonies with >50 cells were
counted. Data are shown as mean SE of four
individual experiments. P values show
comparisons to their respective control media
in the absence of LDL.
Fig. 2. Effect of neutralizing anti-M-CSF on bone marrow progenitor colony
formation in the presence of control or LDL-activated mesangial cell
conditioned medium (8%). Bone marrow cells were grown in the presence
of 0, 25, and 50 rg/ml LDL-activated mesangial cell conditioned media
and in the presence (112) or absence (U) of saturating concentrations of
murine anti-M-CSF. After seven days of incubation, colonies with > 50
cells were counted. Data are shown as mean SE for four individual
experiments. P values show comparisons between LDL-activated condi-
tioned media and their respective controls.
Further characterization of mesangial cell M-CSF expression
was performed in primary cultures and SV-40 transformed murine
mesangial cells using Northern blot analysis employing a specific
cDNA probe for murine M-CSF. In preliminary studies, we noted
that both mesangial cell M-CSF gene expression and protein
synthesis were linear up to 48 hours, thus all incubations of LDL
with mesangial cells were performed for 48 hours. The incubation
of SV-40 transformed mesangial cells with LDL (10 to 200 jrg/ml)
stimulated mRNA expression of a secretory form of M-CSF
(transcript size 4.0 kb) in a dose-dependent manner (Fig. 3).
Additional studies were performed to determine the saturating
dose of LDL on SV-40 transformed mesangial cell mRNA
expression. The data from these studies showed that LDL con-
centrations as high as 1 mg/mi did not alter M-CSF mRNA
expression when compared to the M-CSF mRNA message noted
at LDL concentration of 100 j.g/ml (data not shown). To confirm
the validity of the M-CSF gene expression data, comparable
experiments were performed using primary cultures of murine
mesangial cells studied after five passages. The results of these
studies indicated that the incubation of primary murine mesangial
cells with LDL as low as 10 to 50 .tg/ml significantly stimulated
M-CSF mRNA expression (21 to 38% when compared to con-
trols) confirming similar synthetic phenotypic characteristics be-
tween the primary cultured mesangiai cells and cell line. Mem-
brane-bound M-CSF mRNA expression (transcript size 1.5 to 2.0
kb) was not detected either in control or LDL-activated mesangial
cells. Quantitative analysis of the M-CSF gene expression was
performed by calculating the ratio of the densitometric intensity
of mRNA M-CSF signal to that of the respective GAPDH and
expressed as percent induction of mRNA by LDL-activated
mesangial cells when compared to controls. The data from these
studies indicated that the incubation of mesangial cells with LDL
as low as 50 j.g/ml significantly induced M-CSF mRNA expression
(52% when compared to controls, Fig. 4). The effect was maximal
at an LDL concentration of 100 j.tg/ml (183%).
Western blot analyses of LDL-activated mesangial cell condi-
tioned media were performed to determine the translation of
increased mRNA expression of M-CSF into protein synthesis and
secretion. Incubation of mesangial cells with LDL (10 to 100
j.tg/ml) increased the intensity of immunoreactive bands (20 to 22
kD) in a dose dependent manner as an index of enhanced M-CSF
protein synthesis and secretion into the media (Fig. 5). Quantita-
tive analysis of M-CSF immunoblots by densitometric scanning
revealed that the exposure of mesangial cells to LDL induced
M-CSF synthesis and secretion with LDL concentrations as low as
10 tg/ml (30% induction when compared to control) and the
effect was maximal at LDL concentrations of 100 j.tg/ml (163%
induction, Fig. 6).
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Fig. 3. Effect of LDL on murine mesangial cell
gene expression of M-CSF by Northern blot
analysis. After incubation of mesangial cells
with LDL (0 to 200 jrglml) for 48 hours, cell
monolayers were washed with PBS and RNA
isolated, electrophoresed, and transferred onto
nylon membranes. Northern blots were
hybridized with 32P-labeled murine eDNA
probe for M-CSF and then rehybridized with a
probe for GAPDH. Autoradiographs were
developed by exposing blots to X-ray films.
Lanes represent the incubation of mesangial
cells with LDL: 1, LDL 10 jig/mI; 2, LDL 25
jig/mI; 3, LDL 50 jig/ml; 4, LDL 100 jig/mI; 5,
LDL 200 jig/mI; and 6, control. Northern blot
is representative of four separate experiments.
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activated conditioned media did not alter monocyte proliferation
(data not shown), further suggesting that the monocyte prolifer-
ation activity present in the LDL-activated conditioned media was
the result of mesangial cell secretory products.
Discussion
The increased migration and accumulation of mononuclear
cells within the mesangium, an early pathophysiological cellular
event seen in glomerular injury, often precede the development of
functional and structural changes associated with immune and
nonimmune-mediated renal injury [4—14]. Evidence supporting
the pathobiological role of monocyte/macrophage accumulation
has been derived from experimental models of glomerular injury
including the depletion of renal cortical macrophages by essential
fatty acid diets or by carefully-timed systemic X-irradiation,
mesangial hypercellularity and extracellular mesangial matrix
expansion in rat anti-glomerular basement membrane disease,
remnant kidney models of focal and segmental glomerulosciero-
sis, puromycin aminonucleoside nephrosis, and in animals fed a
high-cholesterol diet to induce glomerular injury [8, 10, 12, 13,
42]. Although macrophage-dependent mechanisms of glomerular
injury are not fully understood, investigators have proposed that
these mononuclear phagocytes, being principal immune effector
cells within the mesangium, may initiate renal injury by enhancing
the synthesis and secretion of various cytoregulatory factors (such
as cytokines, prostanoids, reactive oxygen species, proteolytic
enzymes, etc.) that regulate glomerular cell proliferation, extra-
cellular matrix production, and the functional and structural
integrity of the glomerulus [4, 43].
The identity of potential endogenous biological modifiers that
might trigger the pathophysiological glomerular events induced by
macrophage- or other glomerular-derived cytoregulatoiy factors
is not known. However, since hyperlipoproteinemia and the
accumulation of atherogenic lipoproteins within the mesangium
are often associated with progressive renal injury, we and others
have proposed that these lipoproteins may act as a pathophysio-
logical endogenous modifier that activate resident glomerular
cells to synthesize monocyte chemoattractants and adhesion mol-
ecules that ultimately facilitate the migration and accumulation of
mononuclear cells within the mesangium [44, 451. Supporting this
hypothesis are studies demonstrating that peritoneal macro-
phages, obtained from hypercholesterolemic rats, manifested
increased adhesion to eridothelial cell nionolayers and released
mitogenic and chemotactic substances for vascular smooth muscle
cells into the culture medium [46, 47].
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Fig. 4. Quantitative analysis of the effect of LDL on mesangial cell M-CSF
mRNA expression. After developing the Northern blots, quantitation of
M-CSF mRNA signals on the autoradiographs was performed using a
LKB-Ultra scan laser densitometer and results were normalized to the
respective GAPDH signal. Data are expressed as the percent induction of
M-CSF mRNA by LDL-activated mesangial cells when compared to
controls. Values are mean SE of four individual experiments. P values
represent comparisons between LDL-activated mesangial cells and controls.
The ability of LDL-activated mesangial cell conditioned media
to stimulate monocyte/macrophage proliferation was examined by
measuring 3H-thymidine incorporation into cellular DNA using a
murine monocyte/macrophage cell line (J774.A1). Incubation of
LDL-activated mesangial cell conditioned media at LDL concen-
trations of 25 and 50 jig/mI with murine monocytes stimulated the
incorporation of 3H-thymidine by 63 and 70% respectively as
compared to a control mesangial cell supernatant in the absence
of LDL-activation (Fig. 7), Additional monocyte/macrophage
proliferation studies were performed using neutralizing anti-M-
CSF to determine whether M-CSF secreted into the media by
mesangial cells in response to LDL was a stimulating factor for
monocyte proliferation. The addition of neutralizing anti-M-CSF
to monocyte cultures markedly inhibited the proliferation of
monocytes induced by mesangial cell conditioned media either in
the presence or absence of LDL-activation (Fig. 7). Since LDL
may independently influence monocyte proliferation, additional
studies were performed with equivalent concentrations of exoge-
nous LDL (25 and 50 jig/mI) to examine monocyte proliferation.
These studies indicated that the incubation of exogenous LDL
with murine monocyte/macrophages, but in the absence of LDL-
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Fig. 5. Effect of LDL on mesangial cell M-CSF protein synthesis and secretion by Western blot analysis. Aliquots of mesangial cell conditioned media (25-
to 30-fold concentrated) were electrophoresed under reducing condition and transferred onto a nitrocellulose membrane. Western blots were incubated
with rat anti-mouse M-CSF (1:1000 dilution) for one hour at 25°C, washed and then incubated with peroxidase-conjugated rat anti-IgG (1:1000 dilution)
at 25°C for one hour. After washing, the membranes were incubated with a color reagent to visualize immuno-reactive bands. Lanes represent
immunoreactive bands of mesangial cell M-CSF in response to LDL-activation: 1, control; 2, LDL 10 g/ml; 3, LDL 25 .rgIml; 4, LDL 50 jtg/ml; 5, LDL
100 g/ml; 6, LDL 200 pg/mI; 7, molecular weight markers. Western blot is a representative of three individual experiments.
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Fig. 6. Quantitative analysis of the effect of LDL on mesangial cell M-CSF
protein synthesis and secretion. Experimental details for Western blot
analysis are described in Figure 5 and within the text. After developing the
Western blots with a color reagent, quantitation of M-CSF immunoreac-
tive bands was performed using a LKB-Ultrascan laser densitometer and
results represent relative optical densities. Values are mean SE of three
individual experiments. P values represent comparisons between LDL-
activated mesangial cells and controls.
In the present investigation, we examined the effect of LDL, an
atherogenic lipoprotein, on mesangial cell mRNA expression and
protein synthesis of M-CSF, a cytokine associated with the
migration and proliferation of monocyte/macrophages. Studies
also examined the ability of LDL-activated mesangial cell secre-
tory products to promote bone marrow progenitor colony forma-
tion and to stimulate the proliferation of murine macrophages.
The activation of mesangial cells in the presence of LDL resulted
in an increased gene expression and protein synthesis of M-CSF.
Previous studies by Brennan et al [48] by using cultured mesangial
cells from autoimmune MRL-/pr mice have indicated the presence
of a membrane form of M-CSF. However the other studies in both
Fig. 7. Effect of LDL-activated mesangial cell conditioned media on mono-
cyte/macrophage proliferation. Conditioned media were obtained from the
incubation of mesangial cells with 0, 25, and 50 j.tg/ml of LDL. Aliquots of
mesangial cell conditioned media (60 1d) were added to murine monocyte/
macrophage cultures (J774.A1, a cell line) and incubated in RPMI-1640
media for 48 hours at 37°C. Eight hours before harvesting, the individual
wells were pulsed with 3H-thymidine (0.5 Ci), washed with PBS, and cells
collected on glass wool fiber filters and radioactivity measured. Similar
experiments were performed in the presence of saturating concentrations
of murine anti-M-CSF. Results represent the incorporation of 3H-thymi-
dine into cellular DNA as an index of cell proliferation. Values are mean
SE of three individual experiments. P values represent comparisons
between LDL-activated mesangial cell supernatant and the respective
control.
human and murine mesangial cells have shown the presence of a
secretory form of M-CSF (encoded by a 4.0 kb transcript) without
any expression of a membrane-bound M-CSF (encoded by a 1.5 to
2.0 kb transcript). In the present study, we did not observe any
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presence of 1.5 to 2.0 kb mRNA transcripts for membrane-bound
M-CSF. In addition, we did not observed the presence of 31 kD
membrane bound M-CSF in cell lysates as assessed by Western
analyses as reported earlier by Brennan et al [48].
The LDL-activated mesangial cell media was capable of induc-
ing bone marrow progenitor colony formation of predominantly
monocytic cells in a dose-dependent manner. The addition of
neutralizing anti-M-CSF to the bone marrow progenitor cultures
in the presence or absence of LDL-activated mesangial cell media
resulted in a significant decrease in progenitor cell colony forma-
tion showing that the M-CSF synthesized and released into the
media was biologically active. Since neutralizing anti-M-CSF
incompletely blocked the activity of LDL-activated mesangial cell
supernatant to inhibit the growth of progenitor colony formation,
the contribution of GM-CSF, or other cytokines such as interleu-
kin-i and interleukin-6 (cytokines that have also been shown to
induce myelopoiesis mediated by the enhanced expression of
various CSF) may also play an important role in LDL mediated
augmentation of the growth of bone marrow progenitor cells [49,
50]. In this regard, LDL-activated mesangial cell supernatants in
the presence of anti-GM-CSF neutralized 30 to 40% of bone
marrow progenitor colony formation activity (V.S. Kamanna, R.
Pai and M.A. Kirschenbaum, unpublished observations), suggest-
ing that LDL may also influence mesangial GM-CSF synthesis
and secretion, and that the stimulation of the expression of this
CSF may have contributed to the incomplete blockage of LDL-
activated mesangial supernate in presence of anti-M-CSF to
inhibit progenitor colony formation. Thus, our studies provide
direct evidence to support the hypothesis that atherogenic li-
poproteins serve as potent monocyte chemoattractants, in part, by
inducing mesangial cell M-CSF synthesis and secretion and by
that facilitating the migration of circulating monocytes into the
glomerulus.
Although the mechanisms underlying the pathogenesis of ath-
erosclerosis have been extensively studied, the role of native and
modified atherogenic lipoproteins has been thought to be prom-
inently in the transformation of macrophages into lipid-laden
foam cells of the vascular atherosclerotic plaque [51]. Recently, it
has been recognized that endothelial activation or subendothelial
cellular activation (including smooth muscle cells of the vascular
wall and mesangial cells of the glomerulus) may result in quanti-
tative changes in the levels of expression of specific gene products
of cellular proteins that, in turn, alter normal homeostasis and
provoke the genesis and progression of atherosclerotic and,
perhaps, glomerulosclerotic lesions [52, 53]. In support of our
observations that LDL induces M-CSF expression in mesangial
cells, recent studies have shown that minimally-modified LDL
(but not native LDL) resulted in a rapid induction of vascular
endothelial cell expression of M-CSF [54]. Because of these
findings in nonglomerular cells, we examined the possibility that
handling or storage of the LDL samples resulted in their oxidiza-
tive modification. As noted in the methods section, LDL samples
used in this study contained antioxidants and protease inhibitors
during LDL isolation and were stored at 4°C. Flectrophoretic
mobility on agarose gels was used to assess the oxidative modifi-
cation of the LDL samples and showed no difference in electro-
phoretic mobility between freshly isolated or stored LDL samples,
confirming that no LDL modification occurred. Since mesangial
cells can oxidatively modify and metabolize LDL [55, 56], we
examined the possibility that LDL modification occurred during
the incubation of mesangial cells with the lipoprotein. LDL
samples obtained after 48-hour incubations with mesangial cells
showed no evidence of oxidative modification as assessed by
electrophoretic mobility on agarose gels. The inability of mesang-
ial cells to oxidatively modify LDL in this study may be attributed
to the presence of the agents that were added to freshly isolated
LDL samples (such as antioxidants, protease inhibitors, etc.).
These data indicated that there was no oxidation of LDL during
the incubation period supporting that the results observed were
from specific effects of LDL rather than from oxidative modifica-
tion of LDL. Thus, unlike studies performed in nonrenal vascular
cells, we have shown that native LDL can induce mesangial cell
M-CSF expression. Furthermore, the intravenous administration
of minimally-modified LDL in mice increased the circulating
concentrations of biologically-active M-CSF [57]. Additionally, an
increased gene expression of M-CSF has been noted in all of the
cell types within the atherosclerotic lesions of cholesterol-fed
rabbit and human aorta suggesting that the augmented expression
of M-CSF contributed to the increased infiltration of circulating
monocytes into the subendothelial space in response to hyperlip-
idemia [54, 58]. Other cytokines may also play an important role
in stimulating the expression of M-CSF by arterial and glomerular
cells. Several recent in vitro studies have suggested that interfer-
on-y, tumor necrosis factor-a, interleukin-1/3, interleukin-6 and
GM-CSF are capable of inducing the expression of M-CSF by
monocytes, fibroblasts and mesangial cells [59, 60]. When M-CSF
was administered to experimental animals, it increased the clear-
ance of apolipoprotein B-containing lipoproteins [61] and en-
hanced macrophage degradation of acetyl-LDL [62] showing that
M-CSF could directly influence receptor-mediated catabolism of
lipoproteins.
Apart from augmenting the cellularity of glomerular mesangial
cells, macrophage proliferation also appears to contribute signif-
icantly to the pathogenesis of glomerulosclerosis and vascular
atherosclerosis [63, 64]. Since in vitro studies have indicated that
M-CSF stimulated the proliferation of macrophages, the localized
enhanced expression of M-CSF in response to atherogenic Ii-
poproteins may stimulate glomerular macrophage proliferation.
In this regard, we have shown in the present investigation that
M-CSF released in the mesangial cell supernatant in response to
LDL activation stimulated the proliferation of monocyte/macro-
phages suggesting that the M-CSF was biologically active and may
also serve as a maintenance and proliferative factor for resident
glomerular macrophages. Although M-CSF is vital in regulating
mononuclear cell infiltration into the mesangium, other cytokines,
particularly MCP-i, may also serve as a specific monocyte che-
moattractant. In this regard, recent studies [65, 661 have indicated
that LDL induced mesangial cell MCP-1 expression and mono-
cyte chemoattraction.
In summary, we have shown evidence that LDL, an atherogenic
lipoprotein, can induce the mesangial cell gene expression and
protein synthesis of M-CSF. Furthermore, M-CSF released by
LDL-activated mesangial cell was biologically active and was
capable of promoting the growth of bone marrow progenitor cells
and the proliferation of monocyte/macrophages. Based on these
and other studies that have evaluated the expression of M-CSF by
cells of the atherosclerotic plaque, we propose that atherogenic
lipoproteins stimulate the glomerular expression of potent mono-
cyte chemoattractants that facilitate the influx of circulating
monocytes into the glomerulus, stimulate the proliferation of
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monocyte/macrophages, and trigger series of cellular reactions
leading to glomerular injury. Although these in vitro observations
can be extrapolated to an in vivo system, further in vivo studies are
warranted to determine the pathobiological significance of hyper-
lipoproteinemia per se on the genesis and progression of glomer-
uloscierosis mediated by cellular expression of various cytokines
that are associated with cellular and molecular events leading to a
disturbance in structural and functional integrity of the glomeru-
lus.
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